Literature DB >> 22057379

Electrophysiological studies in newly onset type 2 diabetes without visible vascular retinopathy.

M Tyrberg1, U Lindblad, A Melander, M Lövestam-Adrian, V Ponjavic, S Andréasson.   

Abstract

The purpose of this study was to investigate the early alterations of retinal function, assessed with electrophysiology, in newly onset type 2 diabetes patients without vascular retinopathy. Seventeen patients with newly diagnosed type 2 diabetes (duration 7±3 months), without any vascular retinopathy in fundus photographs, were examined with full-field electroretinogram (ERG) and multifocal ERG (mfERG). The results were compared with those of age-matched subjects without diabetes. In the dark-adapted full-field ERG, the a-wave and the 30-Hz flicker implicit times were delayed in diabetes patients compared to controls, P=0.001 and P=0.020. In the first-order kernel of the mfERG, the first positive wave, P1, was delayed in all areas measured. The electrophysiological examinations demonstrate early alterations of retinal function characterised by a delayed a-wave implicit time in the dark-adapted full-field ERG, representing the rod signalling, and alterations in the multifocal ERG reflecting cone and/or postreceptoral function.

Entities:  

Mesh:

Year:  2011        PMID: 22057379     DOI: 10.1007/s10633-011-9298-6

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  24 in total

1.  The optic nerve head component of the human ERG.

Authors:  E E Sutter; M A Bearse
Journal:  Vision Res       Date:  1999-02       Impact factor: 1.886

2.  ISCEV Standard for full-field clinical electroretinography (2008 update).

Authors:  M F Marmor; A B Fulton; G E Holder; Y Miyake; M Brigell; M Bach
Journal:  Doc Ophthalmol       Date:  2008-11-22       Impact factor: 2.379

3.  Electrophysiological changes in juvenile diabetics without retinopathy.

Authors:  S Juen; G F Kieselbach
Journal:  Arch Ophthalmol       Date:  1990-03

4.  Diabetic retinopathy: seeing beyond glucose-induced microvascular disease.

Authors:  David A Antonetti; Alistair J Barber; Sarah K Bronson; Willard M Freeman; Thomas W Gardner; Leonard S Jefferson; Mark Kester; Scot R Kimball; J Kyle Krady; Kathryn F LaNoue; Christopher C Norbury; Patrick G Quinn; Lakshman Sandirasegarane; Ian A Simpson
Journal:  Diabetes       Date:  2006-09       Impact factor: 9.461

Review 5.  Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy.

Authors:  E M Kohner; V Patel; S M Rassam
Journal:  Diabetes       Date:  1995-06       Impact factor: 9.461

6.  UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors.

Authors: 
Journal:  Diabetes Res       Date:  1990-01

7.  Temporal aspects of the electroretinogram in diabetic retinopathy.

Authors:  G H Bresnick; M Palta
Journal:  Arch Ophthalmol       Date:  1987-05

8.  Adolescents with Type 2 diabetes: early indications of focal retinal neuropathy, retinal thinning, and venular dilation.

Authors:  Kevin W Bronson-Castain; Marcus A Bearse; Jessica Neuville; Soffia Jonasdottir; Barbara King-Hooper; Shirin Barez; Marilyn E Schneck; Anthony J Adams
Journal:  Retina       Date:  2009-05       Impact factor: 4.256

Review 9.  Retinal oxygen: fundamental and clinical aspects.

Authors:  Norbert D Wangsa-Wirawan; Robert A Linsenmeier
Journal:  Arch Ophthalmol       Date:  2003-04

10.  Global estimates of the prevalence of diabetes for 2010 and 2030.

Authors:  J E Shaw; R A Sicree; P Z Zimmet
Journal:  Diabetes Res Clin Pract       Date:  2009-11-06       Impact factor: 5.602

View more
  33 in total

1.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

Review 2.  Multifocal electroretinography in diabetic retinopathy and diabetic macular edema.

Authors:  Marcus A Bearse; Glen Y Ozawa
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 3.  Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.

Authors:  Steven F Abcouwer; Thomas W Gardner
Journal:  Ann N Y Acad Sci       Date:  2014-03-27       Impact factor: 5.691

4.  Cone implicit time as a predictor of visual outcome in macular hole surgery.

Authors:  Sten Andréasson; Fredrik Ghosh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-02       Impact factor: 3.117

5.  Reproducibility of Fixed-luminance and Multi-luminance Flicker Electroretinography in Patients With Diabetic Retinopathy Using an Office-based Testing Paradigm.

Authors:  John J Wroblewski; Christa McChancy; Kassandra Pickel; Hunter Buterbaugh; Tyler Wieland; Alberto Gonzalez
Journal:  J Diabetes Sci Technol       Date:  2019-10-22

6.  Baseline haemoglobin A1c influences retinal function after long-term insulin pump therapy.

Authors:  Oliver N Klefter; Stig K Holfort; Michael Larsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-06-25       Impact factor: 3.117

Review 7.  Diabetic retinal neurodegeneration as a form of diabetic retinopathy.

Authors:  Deepak Soni; Pradeep Sagar; Brijesh Takkar
Journal:  Int Ophthalmol       Date:  2021-05-06       Impact factor: 2.031

8.  Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy.

Authors:  Nicholas C Holoman; Jacob J Aiello; Timothy D Trobenter; Matthew J Tarchick; Michael R Kozlowski; Emily R Makowski; Darryl C De Vivo; Charandeep Singh; Jonathan E Sears; Ivy S Samuels
Journal:  J Neurosci       Date:  2021-02-23       Impact factor: 6.167

9.  Functional retinal outcomes in patients with prediabetes and type 2 diabetes.

Authors:  Nicole Karson; Jennyffer Smith; Morgan Jones; Ananya Datta; Kathryn Richdale; Wendy W Harrison
Journal:  Ophthalmic Physiol Opt       Date:  2020-09-21       Impact factor: 3.117

10.  A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy.

Authors:  April Y Maa; William J Feuer; C Quentin Davis; Ensa K Pillow; Tara D Brown; Rachel M Caywood; Joel E Chasan; Stephen R Fransen
Journal:  J Diabetes Complications       Date:  2015-12-09       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.